Citigroup Inc Connect Biopharma Holdings LTD Transaction History

Citigroup Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 09, 2023	SELL	$0.64 - $1.31 $48,330 - $98,927	-75,517 Reduced 35.17%	139,196 $121,000
Q3 2022 Nov 10, 2022	SELL	$0.8 - $1.65 $128,523 - $265,079	-160,654 Reduced 42.8%	214,713 $277,000
Q2 2022 Aug 10, 2022	BUY	$0.56 - $3.25 $209,615 - $1.22 Million	374,314 Added 35547.39%	375,367 $327,000
Q1 2022 May 12, 2022	SELL	$2.46 - $5.92 $4,698 - $11,307	-1,910 Reduced 64.46%	1,053 $3,000
Q4 2021 Feb 10, 2022	BUY	$4.26 - $23.33 $8,370 - $45,843	1,965 Added 196.89%	2,963 $15,000
Q3 2021 Nov 10, 2021	BUY	$18.12 - $28.5 $18,083 - $28,443	998 New	998 $24,000

3.28M

14K

Ticker CNTB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,015,800
Market Cap $44M
Description
Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, focuses on the discovery and development of immune modulators for the treatment of serious autoimmune diseases and inflammation. The company's lead product candidate is CBP-201, an anti-interleukin-4 receptor alpha antibody, which is in Phase IIb clinical trial for t...

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

Stay updated on Citigroup Inc with notifications on news.